Department of Biomedical Engineering, The University of Texas at Austin, Austin, Texas 78712, USA.
Tissue Eng Part A. 2010 Sep;16(9):2709-20. doi: 10.1089/ten.TEA.2009.0707.
Generation of early T cells by coculturing stem cells on notch-ligand-expressing OP9 stromal cells (OP9-DL1) has been widely reported. However, further differentiation of these cells into mature, antigen-specific, functional T cells, without retroviral transduction of T cell receptors (TcRs), is yet to be achieved. In the thymic niche this differentiation is controlled by the interaction of developing TcRs with major histocompatibility (MHC) molecules on stromal cells. We hypothesized that by providing exogenous antigen-specific MHC/TcR signals, stem and progenitor cells could be engineered into functional, effector T cells specific for the same antigen. Here we demonstrate that both thymus-derived immature T cells (double positive [DP]: CD4+CD8+) and mouse embryonic stem cells can be efficiently differentiated into antigen-specific CD8+ T cells using either MHC tetramers or peptide-loaded stromal cells. DP cells, following MHC/TcR signaling, retained elevated recombination activating gene-1 levels, suggesting continuing TcR gene rearrangement. Both DP and embryonic stem-cell-derived CD8+ T cells showed significant cytotoxic T lymphocytes activity against antigen-loaded target cells, indicating that these cells are functional. Such directed differentiation strategy could provide an efficient method for generating functional, antigen-specific T cells from stem cells for potential use in adoptive T cell therapy.
通过在表达 Notch 配体的 OP9 基质细胞(OP9-DL1)上共培养干细胞来产生早期 T 细胞已被广泛报道。然而,这些细胞进一步分化为成熟的、抗原特异性的、功能性 T 细胞,而无需逆转录病毒转导 T 细胞受体(TcR),这尚未实现。在胸腺龛中,这种分化受发育中的 TcR 与基质细胞上主要组织相容性(MHC)分子的相互作用控制。我们假设通过提供外源性抗原特异性 MHC/TcR 信号,可以将干细胞和祖细胞工程化为针对相同抗原的功能性、效应 T 细胞。在这里,我们证明使用 MHC 四聚体或负载肽的基质细胞可以有效地将来自胸腺的未成熟 T 细胞(双阳性 [DP]:CD4+CD8+)和小鼠胚胎干细胞分化为抗原特异性 CD8+ T 细胞。在 MHC/TcR 信号作用后,DP 细胞保留了高水平的重组激活基因-1,表明 TCR 基因重排仍在继续。DP 和胚胎干细胞衍生的 CD8+ T 细胞对负载抗原的靶细胞均显示出显著的细胞毒性 T 淋巴细胞活性,表明这些细胞具有功能。这种定向分化策略可以为从干细胞中产生功能性、抗原特异性 T 细胞提供一种有效的方法,用于潜在的过继性 T 细胞治疗。